GHUCCTS

News

Share This
  • Oct 22, 2020

TIN convalescent plasma study by former GHUCCTS KL2 scholar Dr. Seble Kassaye featured on NBC4

Dr. Seble Kassaye, infectious disease expert at Georgetown University Medical Center and former GHUCCTS KL2 scholar, is the principal investigator for a local convalescent plasma COVID-19 clinical trial. Dr. Kassaye recently appeared on NBC4 Washington to discuss the trial.

This trial is led by Johns Hopkins University. MedStar Georgetown University HospitalMedStar Washington Hospital Center, and Georgetown University Medical Center are serving as subsites for the trial, with support from GHUCCTS and the Trial Innovation Network (TIN). This study is for people at high risk of exposure to COVID-19, such as hospital personnel (clinical staff, environmental services, dining services, etc) or anyone who is caring for someone with COVID-19. This study will test whether an infusion of plasma containing antibodies from persons who have recovered from COVID-19 can prevent others from getting it.

Please visit www.covidplasmatrial.org/ or call 888-506-1199 for more information. 

Promotional flyer for Dr. Kassaye's COVID-19 plasma trial. Visit covidplasmatrial.org for more details.

Related News

GHUCCTS announces 2022 KL2 Scholar Dr. Amanda Blair Spence

Nov 07, 2022

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Amanda Blair Spence, MD as the 2nd KL2 Scholar selected in our highly-competitive 2022 cycle. This new awardee, her research projects, and training plan are emblematic of our program objectives in that they pair a highly-promising junior faculty scholar-trainee with a mentor team that includes senior colleagues from across disciplines, departments, campuses, and institutions to pursue research that depends upon collaborations and methods from outside the scholars’ discipline, local research environment, or past experiences.

2022 DC CTSA Conference Recordings

Nov 01, 2022

Session recordings are now available from the DC CTSA Consortium's 2022 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research.

2022 REKS Summer Series Recording: Regulatory and Ethics in Innovative Community Research

Oct 25, 2022

Recordings for the 2022 REKS Summer Series are now available. The goal of these series is to highlight and discuss innovative community research, regulatory requirements, and ethical implications.

Close